ライフサイエンスコーパス: pure red-cell aplasia

1 yasthenia gravis, hypogammaglobulinemia, and pure red cell aplasia.

2 and, unlike EPO products, reduce the risk of pure red cell aplasia.

3 atible transplant and may be associated with pure red cell aplasia.

4 set disorders), the most common of which was pure red-cell aplasia.

5 s the disorder most commonly associated with pure red cell aplasia, (2) the presence of clonal cytoge

6 stent infection may develop that presents as pure red cell aplasia and chronic anemia.

7 orders, including transient aplastic crisis, pure red cell aplasia, and hydrops fetalis.

8 he association between rituximab therapy and pure red cell aplasia, but the diagnostic and therapeuti

9 receptor can correct anemia in patients with pure red-cell aplasia caused by antierythropoietin antib

10 nus, graft-vs-host disease-like colitis, and pure red cell aplasia, different from the pattern observ

11 of more than 80 percent in the incidence of pure red-cell aplasia due to Eprex.

12 We obtained reports of epoetin-associated pure red-cell aplasia from the Food and Drug Administrat

13 sease (erythema infectiosum) in children and pure red cell aplasia in immunocompromised patients.

14 e identified 47 adult patients with acquired pure red cell aplasia (median age, 64 years; range, 22 t

15 globin and heme synthesis may be involved in pure red cell aplasia of DBA.

16 patients with chronic kidney disease who had pure red-cell aplasia or hypoplasia due to antierythropo

17 Delayed donor red cell engraftment and pure red cell aplasia (PRCA) are well-recognized complic

18 Acquired pure red cell aplasia (PRCA) can be associated with lymp

19 d 47 months, respectively, before developing pure red cell aplasia (PRCA) confirmed by bone marrow bi

20 Pure red cell aplasia (PRCA) is a rare complication in p

21 Pure red cell aplasia (PRCA) is a rare hematological dis

22 Pure red cell aplasia (PRCA) is a syndrome defined by a

23 munoglobulin (IVIG) therapy in patients with pure red cell aplasia (PRCA) related to human parvovirus

24 eveloped antibodies to epoetin, resulting in pure red cell aplasia (PRCA).

25 ing antibodies leading to the development of pure red cell aplasia (PRCA).

26 Pure red-cell aplasia (PRCA) is a rare hematologic disea

27 equence of this effect of rituximab therapy: pure red cell aplasia resulting from chronic parvovirus

28 Pure red-cell aplasia was defined as transfusion-depende

29 oute of administration, the country in which pure red-cell aplasia was identified, and the date on wh

30 After the peak incidence of Eprex-associated pure red-cell aplasia was reached in 2001, interventions

31 Between 1988 and 1998, antibody-associated pure red-cell aplasia was reported in three patients who

32 plasia was identified, and the date on which pure red-cell aplasia was reported.

33 natural history and therapeutic response of pure red cell aplasia we have studied 37 patients.

34 April 2004, 175 cases of epoetin-associated pure red-cell aplasia were reported for Eprex, 11 cases